RAPS Convergence 2024
In-Person 
510(k)AdvancedAdvanced manufacturingAdvanced therapies/cell and gene therapyAdverse eventsAdvertising, Promotion and LabelingAdvisory committeesAntimicrobial resistanceAPIsApproval/marketing authorizationArtificial intelligence/machine learning (AI/ML)Audit/inspectionBiologics/ biosimilars/ vaccinesBiotechnologyCAPACBERCDERCDRHChemistry, Manufacturing and Controls (CMC)Clinical outcome assessmentCombination productsCombination products/companion diagnosticsCompanion diagnostics (CDx)ComplianceCosmeticsCybersecurityDiagnostics/IVDsDigital health/SaMD/AIEnvironmentalEthicsEthics/Professional ConductExpertFoundationalGCPGDPGenericsGlobalGLPGMPHealth Authority meeting and communication strategyIntermediateMedical device reportingMedical DevicesNutritional/Natural HealthOTCOtherPharmaceuticalsPharmacovigilancePreclinicalPreclinical studyProduct developmentProduct LifecycleProject managementQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory strategyRegulatory writing/documentationResearch, Design and DevelopmentRisk managementSupply Chain ManagementUDI/UDI-DIUS Food and Drug Administration (FDA)